Invasion of brain microvascular endothelial cells (BMECs) is a key step in the pathogenesis of meningitis due to Escherichia coli and Listeria monocytogenes. Although host cell actin cytoskeletal rearrangements are essential in BMEC invasion by E. coli K1 and L. monocytogenes, the underlying signaling mechanisms remain unclear. This study demonstrates that host cell cytosolic phospholipase A 2 (cPLA 2 ) contributes to E. coli K1 invasion of BMECs but not to L. monocytogenes invasion of BMECs. This difference was observed with 4-bromophenacyl bromide, a nonselective PLA 2 inhibitor, and arachidonyl trifluoromethyl ketone, a selective cPLA 2 inhibitor, and was confirmed with BMEC derived from cPLA 2 knockout mice. Activation of cPLA 2 leads to generation of intracellular arachidonic acid, which is metabolized via cyclooxygenase (COX) and lipo-oxygenase (LOX) pathways into eicosanoids. COX and LOX inhibitors also significantly inhibit E. coli K1 invasion of BMECs.
BMEC invasion by E. coli K1 and L. monocytogenes remain incompletely understood.
While examining a potential role for host cell heterotrimeric G proteins in bacterial invasion of BMECs, we found that isotetrandrine, an inhibitor of G protein activation of phospholipase A 2 (PLA 2 ) [12, 13] , inhibited E. coli K1 invasion of BMECs. Isotetrandrine did not exhibit such inhibitory effect on L. monocytogenes invasion of BMECs. This prompted us to further investigate the role of host cell PLA 2 in invasion of BMECs by these bacteria.
In mammalian cells, PLA 2 is important in several pathophysiologic conditions, by producing precursors of inflammatory molecules from phospholipids-such as platelet-activating factor, prostaglandins, thromboxane, and leukotrienes-which are collectively known as eicosanoids [14] . PLA 2 hydrolyzes phospholipids at their sn-2 position, resulting in the release of lysophospholipids and fatty acids, especially arachidonic acid (AA), which is abundant at the sn-2 position. Previous studies have linked activation of PLA 2 and AA metabolites, generated through the cyclooxygenase (COX) and lipo-oxygenase (LOX) pathways, with actin cytoskeletal rearrangement in eukaryotic cells [15] . PLA 2 activation is also important in Salmonella typhimurium invasion of epithelial cells through an epidermal growth factor (EGF) receptor-mediated pathway, although there was no mention of any specific PLA 2 subclass involvement [16] .
PLA 2 can be classified into 12 groups [17] , but, conventionally, 3 main forms of PLA 2 are described: Ca 2ϩ -dependent secretory PLA 2 (sPLA 2 ) of ∼14 kDa in molecular mass, Ca 2ϩ -independent PLA 2 (iPLA 2 ), and Ca 2ϩ -dependent 85-kDa cytosolic PLA 2 (cPLA 2 ) [14, 18, 19] . Intracellular AA release is mediated primarily by cPLA 2 . sPLA 2 has been associated with antibacterial activity against both gram-positive and gram-neg- ative bacteria [20, 21] , and iPLA 2 has been associated with fatty acid remodeling of membrane phospholipids [19] .
Materials and Methods
Reagents. Isotetrandrine (inhibitor of G protein activation of PLA 2 ), arachidonyl trifluoromethyl ketone (AACOCF 3 ; selective cPLA 2 inhibitor), bromoenol lactone (BEL; selective iPLA 2 inhibitor), and 12 episcalaradial (selective sPLA 2 inhibitor) were purchased from Biomol Laboratories. We purchased 4-bromophenacyl bromide (BPB; PLA 2 inhibitor) from Sigma Laboratories. We purchased indomethacin, nordihydroguaiaretic acid (NDGA), and NS-398 from Cayman Chemical.
Bacterial strains. E. coli K1 strain E44, a spontaneous rifampin-resistant mutant of the cerebrospinal fluid isolate RS218 (O18: K1:H7), was obtained from a neonate with meningitis [9] . The control noninvasive E. coli was laboratory strain HB101 [5] . L. monocytogenes Sv 1/2a EGD wild-type strain and WL-111 noninvasive strain (in-frame inlB deletion of strain EGD) were as described elsewhere [8] . E. coli strain E44 and L. monocytogenes strain EGD invade BMECs [5] [6] [7] [8] . All bacteria were grown for 14 h at 37ЊC in brain-heart infusion broth (Difco Laboratories), except E44, which was grown under the same conditions in the presence of rifampin (100 mg/mL).
BMECs. Human BMECs (HBMECs) were isolated from small fragments of cerebral cortex obtained from surgical resections of 4-7-year-old children undergoing neurosurgery for seizure disorders, as described elsewhere [22] . Mouse BMECs (MBMECs) were isolated from 2-month-old C57b6 ϫ Sv129 mice with and without cPLA 2 gene deletion [23] , as described elsewhere [22] .
BMEC invasion assay. The BMEC invasion assay was performed as described elsewhere [5] . In brief, confluent BMECs in 24-well plates were incubated with у10 7 E. coli K1 or L. monocytogenes (MOI of 100) in experimental medium (1:1 of M199:Ham F-12 containing 5% heat-inactivated fetal bovine serum) for 1.5 h at 37ЊC. The monolayers were washed and incubated with experimental medium containing gentamicin (100 mg/mL) for 1 h, to kill extracellular bacteria. The monolayers were washed again and were lysed with 0.5% Triton X-100. Bacterial viability was not affected by treatment with 0.5% Triton X. The released intracellular bacteria were enumerated by plating on sheep blood agar. Bacterial invasion was calculated by the following formula: percentage number invasion p ( of bacteria of bacteria inoculated . recovered/number ) ϫ 100 Percentage invasions were compared between the invasive wildtype bacteria under different conditions (in the presence of inhibitors or use of cPLA 2 gene-deleted BMECs). The results were expressed as relative invasion, where 100% equaled wild-type bacterial invasion in the absence of either inhibitors or cPLA 2 gene knockout BMECs. The bacterial invasion percentages in the absence of either inhibitors or gene knockout BMECs were 0.1% and 0.08% for E. coli K1 in HBMECs and MBMECs, respectively, and 3.98% and 3.55% for L. monocytogenes in HBMECs and MBMECs, respectively. Each experiment was done in triplicate and was repeated у3 times. Where appropriate, the BMEC monolayers were pretreated with inhibitors for 30-60 min before incubation with bacteria.
Thiazolyl blue (MTT) and bactericidal assays. To test for the viability of BMECs in the presence of various inhibitors, we performed the MTT assay, as described in the protocol supplied by the manufacturer (Sigma). Bactericidal assays were done for both E. coli K1 and L. monocytogenes with the various inhibitors mentioned at doses twice those used for the experiments. Experiments with bacteria pretreated for 60 min with maximum doses of inhibitors before incubation with the BMEC monolayers showed no difference in invasion of BMECs by these bacteria, compared with untreated bacteria (data not shown).
Results

Effect of isotetrandrine on invasion of
BMECs by E. coli K1 and L. monocytogenes. While investigating the potential role of G proteins in bacterial invasion of BMECs, we observed that E. coli K1 invasion of BMECs was inhibited by isotetrandrine, a known inhibitor of G protein activation of PLA 2 , but no such inhibition was seen with L. monocytogenes invasion of BMECs (figure 1). There was a concentration-dependent inhibition of E. coli K1 invasion of BMECs, with 90% inhibition at 5 mM. Inhibition of E. coli K1 was the same whether BMECs were pretreated with isotetrandrine for 1 h or overnight [25, 26] , inhibited E. coli K1 invasion of BMECs, but no such inhibition was noted with L. monocytogenes invasion of BMECs ( figure 3) . The IC 50 of AACOCF 3 for inhibition of cPLA 2 is ∼8 mM in other cell types, such as platelets and U937 monocytes [27] . At doses of 10 and 25 mM, there was ∼70% inhibition of E. coli K1 invasion of BMECs. There was no significant inhibition of L. monocytogenes invasion of BMECs at either dose. These findings suggested a differential role of host cell cPLA 2 in the invasion of BMECs by these 2 bacteria.
Effect of BEL and 12-episcalaradial on BMEC invasion by E. coli K1 and L. monocytogenes. When we further investigated the role of other PLA 2 subclasses in bacterial invasion of BMECs, we used selective inhibitors against iPLA 2 (BEL) and sPLA 2 (12-episclaradial). The IC 50 of BEL for iPLA 2 inhibition is ∼1 mM [27, 28] , and that for 12-episcalaradial for inhibition of recombinant sPLA 2 is ∼5.4 mM [29] in different cell types. These inhibitors exhibit a greater selectivity for their respective PLA 2 subclasses at those concentrations. At 10 mM for BEL and 5 mM for 12-episcalaradial, there was no significant inhibition of invasion of BMECs by these 2 bacteria (figure 4) . These findings suggested that iPLA 2 and sPLA 2 are not important in the invasion of BMECs by these bacteria.
Effect of host cell cPLA 2 deficiency on bacterial invasion of BMECs by E. coli K1 and L. monocytogenes. Because the results shown above suggested a role for host cell cPLA 2 in E. coli K1 invasion of BMECs but not in L. monocytogenes invasion of BMECs, we then used MBMECs derived from cPLA 2 knockout mice to further verify the role of host cell cPLA 2 . E. coli K1 invasion was significantly less in MBMECs derived from cPLA 2 knockout mice than in MBMECs derived from control mice ( figure 5 ). In contrast, L. monocytogenes invasion of MBMECs did not significantly differ between knockout mice and control mice (figure 5). These results corroborate the findings with AACOCF 3 , the selective cPLA 2 inhibitor. Taken together, they indicate that cPLA 2 is involved in E. coli K1 invasion of BMECs but not in L. monocytogenes invasion of BMECs.
Effect of COX and LOX pathway inhibitors on E. coli K1 invasion of BMECs. After observing the significant role of host cell cPLA 2 only in E. coli K1 invasion of BMECs, we examined further the involvement of downstream signaling molecules linked to cPLA 2 , such as AA metabolites generated via the COX and LOX pathways, in the invasion of BMECs by E. coli K1. Indomethacin, an inhibitor of COX [30, 31] , inhibited E. coli K1 invasion of BMECs in a concentrationdependent manner (figure 6). The maximum inhibition was ∼50% at a concentration of 100 mM, which is twice the IC 50 of this agent in other cell types (figure 6). BMECs are known to express COX-2 [32] [33] [34] . NS-398, the selective inhibitor of COX-2 [35] , was also inhibitory to E. coli K1 invasion of BMECs, with 50% inhibition at 0.1 mM (figure 6). NDGA, an inhibitor of LOX [36] , inhibited E. coli K1 invasion of BMECs in a concentration-dependent manner, with a maximum inhibition of 50% at the IC 50 of ∼10 mM (figure 7). These findings suggested that both COX and LOX pathways are involved in E. coli K1 invasion of BMECs. This concept was further supported by the demonstration that COX and LOX inhibitors have an additive effect on inhibition of E. coli K1 invasion of BMECs (total inhibition, ∼70%) when used in combination ( figure 7 ).
Discussion
We previously demonstrated that BMEC actin cytoskeletal rearrangements are prerequisite for invasion of BMECs by E. coli K1 and L. monocytogenes when we showed that pretreatment of BMECs with cytochalasin D abolished the invasion of BMECs by these bacteria [8, 9] . However, it remains unclear whether intracellular signaling pathways associated with actin cytoskeletal rearrangements for invasion of BMECs are similar for these 2 bacteria. Actin cytoskeletal rearrangements in mammalian cells have been linked to intracellular signaling via metabolites of AA [15] . cPLA 2 is an important mediator of intracellular AA generation in mammalian cells through its preferential hydrolysis of phospholipids at the sn-2 position. Our findings in this study demonstrate that cPLA 2 is important in E. coli K1 invasion of BMECs but not in L. monocytogenes invasion of BMECs, thereby suggesting diverse intracellular signaling pathways in BMEC invasion by these bacteria.
Our data with the use of PLA 2 inhibitors indicate the importance of PLA 2 in E. coli K1 invasion of BMECs. Isotetrandrine, an inhibitor of G protein activation of PLA 2 , inhibited E. coli K1 invasion of BMECs in a concentration-dependent manner but not with L. monocytogenes invasion of BMECs. This distinctive inhibition of E. coli K1 invasion of BMECs by isotetrandrine precluded any nonspecific inhibitory effect on BMECs by this reagent (e.g., altered permeability of the cells or increased intracellular penetration of antibiotics). This prompted our further investigation into the role of host cell PLA 2 in invasion of BMECs by these bacteria. BPB, a nonselective inhibitor of PLA 2 , as expected, inhibited E. coli K1 invasion of BMECs but not L. monocytogenes invasion of BMECs-further highlighting the requirement for E. coli K1 invasion of BMECs. Although host cell PLA 2 is known to be important for S. typhimurium invasion of epithelial cells via the EGF receptor [16] , this is the first demonstration of the requirement for host cell PLA 2 for E. coli K1 invasion of BMECs.
Further investigation with selective inhibitors of the various PLA 2 subclasses indicated the important role of host cell cPLA 2 in E. coli K1 invasion of BMECs. AACOCF 3 , a selective inhibitor of cPLA 2 , inhibited E. coli K1 invasion of BMECs but not L. monocytogenes invasion of BMECs, which suggested differential involvement of host cell cPLA 2 in the invasion of BMECs by these meningeal pathogens. Inhibitors of iPLA 2 (BEL) and sPLA 2 (12-episcalaradial) are more selective for the respective subclasses of PLA 2 at lower doses [28, 29] , on the basis of the IC 50 of these reagents. In our study, the lower doses of these inhibitors exhibited no significant effect on either E. coli K1 or L. monocytogenes invasion of BMECs, which suggests that neither sPLA 2 nor iPLA 2 has any significant role in the invasion of BMECs by these bacteria. These reagents have lower selectivity at higher doses in different cell types [28, 29] . Thus, the inhibition of E. coli K1 invasion of BMECs observed with the higher concentration of the sPLA 2 inhibitor (i.e., 25 mM 12-episcalaradial) could be explained by possible inhibition of cPLA 2 . The higher concentrations of these inhibitors did not inhibit L. monocytogenes invasion of BMECs, thereby excluding the possibility of nonspecific effects on BMECs. Knockout mice lacking cPLA 2 were used previously to elucidate the role of cPLA 2 in fertility and the pathophysiology of postischemic brain injury [23] . These mice were generated by targeted inactivation of cPLA 2 . They develop normally, gain weight at a rate equal to that of wild-type animals, and have life spans 11 year. E. coli K1 invasion was significantly decreased in BMECs derived from cPLA 2 -deficient mice, compared with MBMECs from control mice. These findings corroborate our observation of the important role of host cell cPLA 2 in E. coli K1 invasion of BMECs seen with PLA 2 inhibitors. Furthermore, the significant decline in E. coli K1 invasion in BMECs isolated from cPLA 2 knockout mice excludes the possibility of nonspecific inhibition by AACOCF 3 , the selective cPLA 2 inhibitor. In contrast, there was no significant difference in L. monocytogenes invasion of control and cPLA 2 -deficient MBMECs, which provides further evidence that cPLA 2 does not play a role in L. monocytogenes invasion of BMECs. Taken together, these observations indicate a differential role of host cell cPLA 2 in invasion of BMECs by E. coli K1 and L. monocytogenes.
Activation of cPLA 2 leads to the generation of intracellular AA. AA is the precursor of inflammatory mediators collectively known as eicosanoids (e.g., prostaglandins and leukotrienes). These are generated through either the COX or LOX pathways. Leukotriene synthesis is considered to be necessary for actin polymerization in response to epidermal growth factor, whereas the absence of prostaglandins is detrimental to the breakdown of actin stress fibers in activated cells [15] . We noted ∼50% inhibition of E. coli K1 invasion of BMECs with the separate use of COX and LOX inhibitors. The absence of a concentration-dependent inhibitory effect with the COX-2 inhibitor NS-398 suggests either a nonspecific response or a high sensitivity of the expressed COX-2 in BMECs to low doses of NS-398. Moreover, there appeared to be an increased inhibitory effect of the combined use of COX and LOX inhibitors on E. coli K1 invasion of BMECs. This suggests that AA metabolites generated via both COX and LOX pathways contribute to E. coli K1 invasion of BMECs. Further studies are underway to understand the mechanisms involving AA metabolites in E. coli K1 invasion of BMECs (e.g., how AA metabolites affect actin cytoskeletal rearrangements in response to E. coli K1 invasion of BMECs).
On the basis of our data regarding E. coli K1 invasion of BMECs, we propose that activation of host cell cPLA 2 secondary to E. coli K1-BMEC interactions leads to the generation of AA metabolites and to E. coli K1 invasion of BMECs. Despite the clear demonstration of the importance of host cell cPLA 2 in E. coli K1 invasion of BMECs, the lack of complete inhibition of E. coli K1 invasion of BMECs by AACOCF 3 and the incomplete abolition of E. coli K1 invasion in cPLA 2 knockout BMECs indicate the existence of other host cell signaling molecules and pathways that are important for E. coli K1 invasion of BMECs. Further delineation of host cell intracellular signaling associated with E. coli K1 invasion of BMECs will enable us to better understand the pathogenesis of E. coli K1 meningitis and help in developing novel therapeutic approaches for its prevention and treatment.
